Investor Create sustained value increase for investors Home>Investor Announcements and Circulars Learn More 03-19 2019 OVERSEAS REGULATORY ANNOUNCEMENT (H SHARES) 03-15 2019 OVERSEAS REGULATORY ANNOUNCEMENT (H SHARES) 03-15 2019 OVERSEAS REGULATORY ANNOUNCEMENT (H SHARES) 03-15 2019 OVERSEAS REGULATORY ANNOUNCEMENT (H SHARES) 03-14 2019 OVERSEAS REGULATORY ANNOUNCEMENT (H SHARES) Govemance Learn More 12-27 2018 Board Diversity Policy 12-27 2018 Terms of Reference and Implementation Rules of the Nomination Committee under the Board of Directors 12-27 2018 Terms of Reference and Implementation Rules of the Audit Committee under the Board of Directors 07-31 2018 Articles of Association 10-30 2012 Terms of Reference and Implementation Rules of the Strategic Committee under the Board of Directors Stock Info 600196-SH 18.7 0.120.64% 02196-HK 26.25 0.150.57% Reports 2018 THIRD QUARTERLY REPORT (H SHARES) 2017 Corporate Social Responsibility Report Investor Contact Contact: Li Xinlei Tel：+86-21-33987870 Fax：+86-21-33987020 Mail：ir@fosunpharma.com lixinlei@fosunpharma.com